Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$85.37 - $115.44 $351,041 - $474,689
4,112 New
4,112 $438 Million
Q1 2022

May 13, 2022

SELL
$126.46 - $235.05 $112,549 - $209,194
-890 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$225.82 - $368.51 $33,647 - $54,907
-149 Reduced 14.34%
890 $227,000
Q3 2021

Nov 08, 2021

BUY
$221.9 - $484.47 $230,554 - $503,364
1,039 New
1,039 $400 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Ipg Investment Advisors LLC Portfolio

Follow Ipg Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ipg Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ipg Investment Advisors LLC with notifications on news.